Facebook
Twitter
LinkedIn
ForwardAdvances in Breast Cancer Management: Early Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment (PRO 01)
This activity involves three discussants using case-based presentations to review recent advances in breast cancer treatment. The first discussant addresses when to treat early stage breast cancer patients, including a review of the recent ASTRO APBI guidelines and the IDEA and Lumina 1 trial. The second discussant examines radiation therapy in the post-neoadjuvant setting, including an assessment of the NSABP B-51 results. The third discussant assesses indications and techniques for using breast IMRT.
Target Audience
This activity is designed to meet the needs of medical oncologists and radiation oncologists.
Learning Objectives
After viewing this activity the learner should be able to:
- Discuss treatment options for patients with early stage breast cancer and those treated with neoadjuvant chemotherapy
- Discuss indications and treatment techniques for IMRT in breast cancer patients.
- Christine S. Chung, MD, FASTRO, MPH, is employed by the H. Lee Moffitt Cancer Center.
- Janice Lyons, MD, is employed by University Hospitals Seidman Cancer Center and Case Western Reserve University. Dr. Lyons receives honoraria from Primum. Dr. Lyons serves as Chair of the PBI guidelines committee with ASTRO and is a member of the breast cancer guidelines committee with NCCN and the exam development committee with ABR.
- Lisa Singer, MD, PhD, is employed by University of California, San Francisco. Dr. Singer serves on the Board of Directors with the American Board of MR Safety.
- Laura Warren, MD, is employed by the Dana-Farber Cancer Institute.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.